WANBURY
Back to Balance Sheet
|
WANBURY Last 5 Year Total Non-Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Assets | ₹179 Cr | ₹174 Cr | ₹174 Cr | ₹182 Cr | ₹182 Cr |
What is the latest Total Non-Current Assets ratio of WANBURY ?
Year | Total Non-Current Assets |
---|---|
Mar2024 | ₹179 Cr |
Mar2023 | ₹174 Cr |
Mar2022 | ₹174 Cr |
Mar2021 | ₹182 Cr |
Mar2020 | ₹182 Cr |
How is Total Non-Current Assets of WANBURY Trending?
Years | Total Non-Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹179 Cr | 2.56 | |
Mar2023 | ₹174 Cr | 0.31 | |
Mar2022 | ₹174 Cr | -4.70 | |
Mar2021 | ₹182 Cr | 0.32 | |
Mar2020 | ₹182 Cr | - |
Compare Total Non-Current Assets of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹826.4 Cr | -12.2% | -10% | 118.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹438,143.0 Cr | -2.2% | 1.7% | 41.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,578.0 Cr | -4.6% | -1.6% | 45.8% | Stock Analytics | |
CIPLA | ₹120,185.0 Cr | -2.8% | 1.8% | 15.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹114,450.0 Cr | -0.2% | 9.2% | 15.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹101,569.0 Cr | -0.9% | -0.1% | 41.1% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | -12.2% |
-10% |
118.3% |
SENSEX | -0.5% |
-4.4% |
9.5% |
You may also like the below Video Courses